Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS

J Infect Dis. 1995 Apr;171(4):930-7. doi: 10.1093/infdis/171.4.930.

Abstract

Fifty-eight patients with human immunodeficiency virus infection were analyzed for clinical manifestations and potential risk factors for Pseudomonas aeruginosa infection by use of case-control methodology. Most had AIDS. Of 73 episodes of P. aeruginosa infection, 45 (62%) were bacteremias primarily associated with central venous catheters (16), pneumonia (12), soft tissue (4), or urinary tract infections (4). Twenty-eight episodes (38%) were nonbacteremic, with pneumonia (13), soft tissue infections (6), and sinusitis (4) accounting for the majority of infections. Fifty episodes (68%) were community-acquired. The recurrence rate was 23%. The overall mortality attributable to P. aeruginosa infection was 22%. Central venous and urinary catheter use and steroid therapy were significantly more frequent in cases than controls (P < .05). Thus, P. aeruginosa infection in patients with advanced human immunodeficiency virus disease is often community-acquired and associated with substantial mortality and, in some cases, specific risk factors.

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / etiology*
  • AIDS-Related Opportunistic Infections / physiopathology
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / etiology
  • Case-Control Studies
  • Catheterization, Central Venous
  • Community-Acquired Infections
  • Female
  • HIV Infections / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / etiology
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / etiology*
  • Pseudomonas Infections / physiopathology
  • Retrospective Studies
  • Risk Factors
  • Steroids / therapeutic use
  • Urinary Catheterization

Substances

  • Anti-Bacterial Agents
  • Steroids